04/03/2025 4:32 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2025 3:25 PM | CHIMERIX INC (Subject) Jazz Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
04/01/2025 3:32 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2025 7:35 AM | CHIMERIX INC (Subject) Jazz Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
03/21/2025 5:54 AM | CHIMERIX INC (Subject) Jazz Pharmaceuticals (Filed by)
| Form SC TO-T | |
03/12/2025 1:24 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 5:17 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 5:19 PM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/10/2025 5:01 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025 4:36 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025 5:57 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for JAZZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
03/07/2025 6:00 PM | Jazz Pharmaceuticals (Issuer) Pearce Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 5:43 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 5:45 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 5:49 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 5:51 PM | Jazz Pharmaceuticals (Issuer) Johnson Philip L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 4:14 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025 4:04 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025 2:15 PM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025 3:42 PM | CHIMERIX INC (Subject) Jazz Pharmaceuticals (Filed by)
| Form SC TO-C | |
03/05/2025 3:50 PM | CHIMERIX INC (Subject) Jazz Pharmaceuticals (Filed by)
| Form SC TO-C | |
03/05/2025 6:09 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2025 6:11 AM | Jazz Pharmaceuticals (Subject)
| Form SC TO-C | |
03/03/2025 7:19 PM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 7:22 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 6:35 PM | Jazz Pharmaceuticals (Issuer) Pearce Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 6:24 PM | Jazz Pharmaceuticals (Issuer) Johnson Philip L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 6:29 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 6:13 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 6:18 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 6:21 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 3:44 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025 4:43 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025 7:05 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025 3:56 PM | Jazz Pharmaceuticals (Subject) Patil Neena M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025 6:34 AM | Jazz Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/05/2025 4:41 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 5:55 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 5:58 PM | Iannone Robert (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 5:43 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 5:46 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
This almost killed Elon Musk (chilling details emerge) (Ad) Elon Musk's Near-Death Experience Sparks Dire Warning for Americans
After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late. See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro |
01/22/2025 5:50 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2025 5:40 PM | Jazz Pharmaceuticals (Issuer) Pearce Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/06/2025 3:22 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:43 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/09/2024 5:45 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2024 5:05 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024 3:20 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024 4:02 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2024 5:06 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 4:44 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/12/2024 10:44 AM | BlackRock, Inc. (Filed by) Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024 4:55 PM | Jazz Pharmaceuticals (Subject) Patil Neena M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024 6:32 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/05/2024 4:00 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 2:19 PM | COZADD BRUCE C (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024 3:11 PM | BlackRock, Inc. (Filed by) Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/16/2024 3:13 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2024 10:38 AM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 6:50 PM | Henderson Mary Elizabeth (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024 1:27 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 5:39 PM | Cook Jennifer E. (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 5:39 PM | Jazz Pharmaceuticals (Issuer) McSharry Heather Ann (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 5:40 PM | Jazz Pharmaceuticals (Issuer) O'Keefe Kenneth W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 5:40 PM | Jazz Pharmaceuticals (Issuer) ORiordan Anne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 5:41 PM | Jazz Pharmaceuticals (Issuer) RIEDEL NORBERT G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 5:42 PM | Jazz Pharmaceuticals (Issuer) Smith Mark Douglas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 5:42 PM | Jazz Pharmaceuticals (Issuer) Winningham Rick E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 5:45 PM | ENRIGHT PATRICK G (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 3:48 PM | Hamill Laura (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 3:50 PM | Jazz Pharmaceuticals (Issuer) Kennedy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 3:52 PM | Jazz Pharmaceuticals (Issuer) Mulligan Seamus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 3:53 PM | Jazz Pharmaceuticals (Issuer) Pearce Samantha (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 8:57 PM | Jazz Pharmaceuticals (Subject) Winningham Rick E (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024 8:29 PM | Jazz Pharmaceuticals (Subject) McSharry Heather Ann (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024 8:35 PM | Jazz Pharmaceuticals (Subject) O'Keefe Kenneth W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024 8:42 PM | Jazz Pharmaceuticals (Subject) ORiordan Anne (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024 8:49 PM | Jazz Pharmaceuticals (Subject) RIEDEL NORBERT G (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024 8:55 PM | Jazz Pharmaceuticals (Subject) Smith Mark Douglas (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024 8:19 PM | Cook Jennifer E. (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024 6:33 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024 3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/30/2024 7:11 PM | Hamill Laura (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/22/2024 3:46 PM | Jazz Pharmaceuticals (Filer)
| Form DEFA14A | |
07/22/2024 6:57 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2024 7:15 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:44 PM | Carr Patricia (Reporting) Jazz Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024 4:31 PM | Jazz Pharmaceuticals (Issuer) Patil Neena M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 6:38 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
This almost killed Elon Musk (chilling details emerge) (Ad) Elon Musk's Near-Death Experience Sparks Dire Warning for Americans
After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late. See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro |
04/09/2024 3:39 PM | GALA RENEE D (Reporting) Jazz Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |